the aid library

Filter

467

Лечение лекарственно-устойчивого туберкулеза. Что для этого нужно?

Беверли Коллин, Филипп дю Крос, Натан Форд, Джо Хатчинсон, Наташа Льюэр, Лесли Шэнкс, Франсис Варэн Medecins Sans Frontiers (2011) C2

Брошюра состоит из двух частей. В первой приводятся практические примеры, иллюстрирующие все составляющие ухода за пациентами, во второй части представлены данны� ... more

Meeting of national HIV programme managers of Eastern European, Central Asian and non-EU/EEA countries

World Health Organization (Europe) (2018) C_WHO

Meeting report, 25-26 September 2017 Copenhagen, Denmark

Clinical Guidelines: HIV Diagnosis - Chapter 2

World Health Organization (WHO) World Health Organization (WHO) (2019) C_WHO

Accessed: 29.09.2019

WHO Guidelines on Integrated Care for Older People (ICOPE)
recommended

World Health Organization WHO (2017) C_WHO

he WHO Guidelines on Integrated Care for Older People (ICOPE) propose evidence-based recommendations for health care professionals to prevent, slow or reverse declines in the physical and mental capacities of older people. These recommendations require countries to place the needs and preferences of ... more

HIV/AIDS treatment and care in Belarus

J. D. Lundgren; D. Raben; I. Eramova; V. Ilyenkova World Health Organization (Europe); Centre for Heath & Infectious Disease Research (2014) C_WHO

Evaluation report January 2014

Treatment - Paediatric HIV Care and Treatment

World Health Organization; UNAIDS; Unicef (2009) C_WHO

Working Document - Updated -February 2009

Strategies for Identifying and Linking HIV-Infected Infants, Children, and Adolescents to HIV Care and Treatment

Centers for Diseases Control and Prevention; USAID (2019) C_CDC

Accessed: 08.10.2019

Incidence and Prevalence of Opportunistic and Other Infections and the Impact of Antiretroviral Therapy Among HIV-infected Children in Low- and Middle- income Countries: A Systematic Review and Meta-a

M.-R. B-Lajoie; O. Drouin; G. Bartlett; et al. Clinical Infectious Diseases; Infectious Diseases Society of America (IDSA); hivma; Oxford; WHO (2016) C2

Clinical Infectious Diseases 1586 - 1594 • CID 2016:62 (15 June) • HIV/AIDS

Burden sharing or burden shifting? - HIV and TB

Médecins Sans Frontières (MSF) (2019) C1

MSF provides treatment for HIV and tuberculosis (TB) in more than 20 countries around the world. The report Burden sharing or burden shifting? How the HIV/TB response is being derailed examines the situation in nine countries where MSF runs programmes: Central African Republic, Democratic Republic ... more

Propelling the Pediatric HIV Therapeutic Agenda With Science, Innovation, and Collaboration

E. J. Abrams; J. Ananworanich; M. Archary; M.N. Ngongondo; P. Brouwers J Acquir Immune Defic Syndr; Pub Med (2018) C2

J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018

Key considerations for differentiated antiretroviral therapy delivery for specific populations: Children, adolescents, pregnant and breastfeeding women and key populations

World Health Organization; (CDC) Center for disease control and prevention; USAID; et al. (2017) C_WHO

A Global Research Agenda for Pediatric HIV

M. Penazzato; C. Irvine; M. Vicari; et al Journal of Acquired Immune Deficiency Syndromes (JAIDS); Ovid (2018) CC

Supplement Article www.jaids.com J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018

SADC Minimum Standards for Child and Adolescent HIV, TB and Malaria Continuum Of Care and Support (2013-2017)

SADC (2012) C2

SADC Communicable Disease Project Component 5: Scaling-up Child and Adolescent HIV, TB and Malaria Continuum of Care and Support DRAFT POST REGIONAL CONSENSUS AND VALIDATION MEETING Oct 2012

Mental health and HIV/AIDS: the need for an integrated response

R. H. Remien; M. J. Stirratt; N. Nguyen; et al. AIDS; Wolters Kluwer (2019) CC

Editorial Review AIDS 2019, 33:1411–1420

HEARTS. Technical package for cardiovascular disease management in primary health care. Evidence-based treatment protocols

World Health Organization WHO, et al. (2018) C_WHO

In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles ... more

HEARTS. Technical package for cardiovascular disease management in primary health care. Healthy-living Counselling

World Health Organization WHO, et al. (2018) C_WHO

HEARTS. Technical package for cardiovascular disease management in primary health care. Access to essential medicines and technology

World Health Organization WHO, et al. (2018) C_WHO

Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t ... more

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ... and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

The Burden of Orphans and Vulnerable Children Due to HIV/AIDS in Cameroon

D. S. Nsagha; A.-C. ZK Bissek; S. M. Nsagha; et al. The Open AIDS Journal; PubMed (2012) CC

The Open AIDS Journal, 2012, 6, 245-258

Women: At the heart of the HIV response for children

Unicef (2018)